Industry Experts Present At The 2013 BIO International Convention
ST. LOUIS, April 17, 2013
ST. LOUIS, April 17, 2013 /PRNewswire/ -- The BIO International Convention is
the largest annual eventfor the biotechnology industry. This year's meeting
will feature two leading strategy experts, Rita E. Numerof, Ph.D., President,
and Michael N. Abrams, M.A., Managing Partner of Numerof & Associates, Inc.
They will share perspectives drawn from more than 25 years of experience
working globally across healthcare.
They are each moderating panel sessions on April 23. Rita's session, titled
Massive Health Care Consolidation and Its Impact on Biotech, is scheduled for
10:30am. She'll be joined by Paul Howard, Ph.D. (Manhattan Institute), and
Marc Boutin (National Health Council) in a discussion of how biotech companies
can adapt to a more consolidated marketplace.
Michael's session, at 3:45pm, is titled Demonstrating Product Economic and
Clinical Value: Know What Investors Are Looking For. He, Alexander Natz,
Ph.D. (European Confederation of Pharmaceutical Entrepreneurs), Art Pappas
(Pappas Ventures), and Chris Seaton (Bayer AG) will discuss how biotech
companies can evaluate their products' value and communicate that value to
Rita and Michael will sign copies of their most recent book, Healthcare at a
Turning Point, after their sessions.
2013 BIO International Convention
About Rita Numerof
An internationally recognized consultant, Rita works in dynamic industries
like healthcare that are challenged to develop new business models to adapt to
major market changes. Rita's expertise has helped a wide range of leading
companies to fundamentally reshape and execute new strategy. Her global
cross-industry perspective and expertise in strategy execution are the basis
for objective counsel that leading executives tap into on a regular basis. She
is widely published in business journals and has authored five books,
including Healthcare at a Turning Point: A Roadmap for Change (2013).
About Michael Abrams
Over the past 25 years, Michael has built a portfolio of strategy and business
performance successes as both an internal and external consultant for Fortune
500 corporations on a global basis. Michael is well known for his expertise in
the emerging demand for economic and clinical value, and has helped clients
develop processes and capabilities to successfully compete in highly dynamic
markets. Michael has written extensively on the need for integrated, systemic
solutions to the challenges facing the healthcare industry, and has
co-authored two books, including Healthcare at a Turning Point: A Roadmap for
SOURCE Numerof & Associates, Inc.
Contact: Jordan Rutledge, firstname.lastname@example.org, +1-314-997-1587
Press spacebar to pause and continue. Press esc to stop.